3D LifePrints, a UK-based medical 3D Printing company just secured £500,000 in series A Funding round. This investment follows on from previous Seed Funding investment in 2016 and will contribute to the expansion of the company’s services.
3D LifePrints offers medical 3D printing manufacturing and service capabilities to NHS hospitals & academic institutions. They work in collaboration with clinicians, healthcare providers and academics to identify new applications of 3D technologies.
The investment will enable the medical company to develop its portfolio of embedded medical 3D printing hubs across the NHS and overseas, recruit additional bio-medical engineers and 3D technologists, as well as continuing to invest in Research and Development.
Henry Pinchbeck, Chief Executive Officer said “I’m delighted that Fenwall have invested with us. They are a perfect long-term partner for 3D LifePrints, with a shared set of values and a vision for improving healthcare across the globe.”
Dr. Andrew Douglas, Managing Director of Fenwall Investments Ltd also shares their enthusiasm to be part of this journey. According to them, the timing is perfect to allow 3D LifePrints to capitalise on its potential.
For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!
//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
(adsbygoogle = window.adsbygoogle || []).push({});